News


01/27/15, Aspirin/ASA Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban Study in Patients with a recent Embolic Stroke of Undetermined Source Embolic stroke of undetermined source is caused by a blood clot, and affects approximately 300,000 people each year in North America and Europe / Phase III NAVIGATE ESUS study will investigate once-daily rivaroxaban for the secondary prevention of stroke in approximately 7,000 patients / Indication-seeking trial will be conducted in partnership with Population Health Research Institute and Canadian Stroke Prevention Intervention Network more

Working Together to Combat River Blindness

Agreement between Bayer and the DNDi on the development of a new drug

more

How important to the world is the right to sexual and reproductive self-determination?

This year's International Dialogue on Population and Sustainable Development at the beginning of November was held against a special backdrop. The deadline for the Millennium Sustainable Development Goals which the United Nations had set at the turn of the millennium expires in 2015...

more

A Call for Action Against Unplanned Pregnancies

September 26, 2014: Today is World Contraception Day!
Today, on September 26, is World Contraception Day! To mark the occasion, the WCD Coalition of eleven non-governmental and governmental organizations as well as scientific and medical societies published a joint “Framework for Action”. more

Bayer Clinical Trials

Information about Bayer sponsored clinical studies is available at

Facebook

Facebook Banner

Follow us on Facebook

more

Links


http://pharma.bayer.com/en/index.php

Copyright © Bayer Pharma AG